Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Stada-Arzneimittel    SAZ   DE0007251803

STADA-ARZNEIMITTEL (SAZ)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
10/16/2017 10/17/2017 10/18/2017 10/19/2017 10/20/2017 Date
82.86(c) 82.02(c) 82.06(c) 82.02(c) 82.34 Last
21 661 38 799 28 119 27 211 16 877 Volume
+0.74% -1.01% +0.05% -0.05% +0.39% Change
More quotes
Financials (€)
Sales 2017 2 286 M
EBIT 2017 316 M
Net income 2017 179 M
Debt 2017 1 155 M
Yield 2017 1,04%
Sales 2018 2 420 M
EBIT 2018 336 M
Net income 2018 201 M
Debt 2018 1 030 M
Yield 2018 1,15%
P/E ratio 2017 28,52
P/E ratio 2018 24,35
EV / Sales2017 2,74x
EV / Sales2018 2,54x
Capitalization 5 113 M
More Financials
Company
STADA Arzneimittel AG engages in the provision of healthcare and pharmaceutical products.It operates through the Generics and Branded Products segments.The Generics segment produces and distributes generic drugs.The Branded Products segment sells branded healthcare products and medicines.The... 
Sector
Pharmaceuticals
Calendar
11/09Earnings Release
More about the company
Surperformance© ratings of Stada-Arzneimittel
Trading Rating : Investor Rating :
More Ratings
Latest news on STADA-ARZNEIMITTEL
10/17 STADA ARZNEIMITTEL : Frank Staud assumes overall responsibility for the STADA br..
09/29 STADA ARZNEIMITTEL : Dr. Claudio Albrecht appointed CEO and Mark Keatley CFO of ..
09/28 LPC-Europe's leveraged loan market shows strength and depth
09/28 STADA ARZNEIMITTEL : Dr. Claudio Albrecht appointed CEO and Mark Keatley CFO of ..
09/28 STADA ARZNEIMITTEL AG : Dr. Claudio Albrecht appointed CEO and Mark Keatley CFO ..
09/27 STADA ARZNEIMITTEL : Supervisory Board of STADA Arzneimittel AG elects Dr. Günte..
09/27 STADA ARZNEIMITTEL AG : Supervisory Board of STADA Arzneimittel AG elects Dr. Gü..
09/26 SHANGHAI PHARMACEUTICALS : CVC, others explore sale of drugmaker Alvogen - Bloom..
09/19 STADA ARZNEIMITTEL AG : Release according to Article 26, Section 1 of the WpHG [..
09/19 STADA ARZNEIMITTEL AG : Release according to Article 26, Section 1 of the WpHG [..
More news
Sector news : Generic Pharmaceuticals
11:45aDJABBOTT LABORATORIES : Hacking Is a Risk for Pacemakers. So Is the Fix
10/19DJCELGENE : Halts Crohn's Disease Drug Trials
10/19DJEuropean Corporate Roundup for Thursday
10/19DJEuropean Corporate Roundup for Thursday
10/19DJMERCK AND : Chenault Among Few Black CEOs -- WSJ
More sector news : Generic Pharmaceuticals
4-Traders Strategies on STADA-ARZNEIMITTEL 
STADA ARZNEIMITTEL - 2014
Bearish scenario preferred
SELL
STADA ARZNEIMITTEL - 2014
Into a recovery phase
BUY
More Strategies
Latest Tweets
10/17Stada Arzneimittel : Frank Staud assumes overall responsibility for the STADA.. 
09/25$SAZ - STADA Arzneimittel AG #SAZ Given Consensus Rating of "Sell" by Brokera.. 
09/19STADA Arzneimittel AG: Release according to Article 26, Section 1 of the WpHG.. 
09/19STADA Arzneimittel AG: Release according to Article 26, Section 1 of the WpHG.. 
09/19STADA Arzneimittel AG: Release according to Article 26, Section 1 of the WpHG.. 
More tweets
Qtime:38
News from SeekingAlpha
08/21 MERGER OF EQUALS : Linde Shares More Attractive Relative To Praxair
07/05 Second-Quarter Deals Show A Sector Set On Pause
04/18 SNIPPET ROUNDUP : Aerie Stumbles On Safety; Stada Is Sold At Last
04/18 FOCUS ON EUROPE : Will Marine Le Pen Become France's Next President?
03/29 Stada Arzneimittel's (STDAF) CEO Dr. Matthias Wiedenfels on Q4 2016 Results -..
Chart STADA-ARZNEIMITTEL
Duration : Period :
Stada-Arzneimittel Technical Analysis Chart | SAZ | DE0007251803 | 4-Traders
Technical analysis trends STADA-ARZNEIMITTEL
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 12
Average target price 65,1 €
Spread / Average Target -21%
EPS Revisions
Managers
NameTitle
Claudio Albrecht Chairman-Executive Board
Günter von Au Chairman-Supervisory Board
Mark Burgess Keatley Chief Financial Officer
Barthold Piening Chief Technical Officer
Halil Duru Member-Supervisory Board
Sector and Competitors